Moleculin Biotech Inc (MBRX)

[BooDog]

This could get interesting!!

Although developing in vitro data is an initial step and the data may not necessarily reflect the antiviral effects in vivo, the results of this repeated round of in vitro testing received on June 1, 2020, confirm that WP1122 has an antiviral effect on Human Coronavirus 229E ("HCoV-229E"), a surrogate of SARS-CoV-2, the virus responsible for COVID-19.

"We felt it was important to confirm these results," commented Walter Klemp, Chairman and CEO of Moleculin, "so, out of an abundance of caution, we had an independent testing contractor run them a second time. While the results are encouraging, we believe, based on guidance from the FDA, we will need additional studies to further assess WP1122's antiviral capability, and consistent with our previous guidance, we will continue to push forward with additional in vitro and in vivo testing with the goal of a possible IND filing by the end of 2020, in preparation for beginning a human clinical trial thereafter."



https://finance.yahoo.com/news/moleculin-announces-confirmatory-vitro-analysis-113000953.html